Immunology
Conference Coverage
Screen sooner and more often for those with family history of CRC
A family history of colorectal cancer is associated with risk of colorectal cancer, and screening guidelines should be adjusted accordingly.
Conference Coverage
Olopatadine/mometasone combo is safe and effective
ORLANDO – Combining two safe and effective options for seasonal allergic rhinitis showed even more efficacy with relative safety.
Latest News
Birth cohort affected 2015-2016 flu vaccine effectiveness
Birth year may have an impact on how well the influenza vaccine worked.
Conference Coverage
Immunologic testing is key to diagnosing autoimmune blistering diseases
SAN FRANCISCO – Starting with immunologic testing can spare patients with blistering diseases years of unnecessary overexposure to prednisone.
Conference Coverage
Studies provide insight into link between cancer immunotherapy and autoimmune disease
MADRID – Patients may “require much higher doses – of steroids in particular – to treat their symptoms.”
From the Journals
High allele level linked to lamotrigine-induced SCAR
Could higher frequency of alleles associated with drug-induced severe cutaneous adverse reactions be specific to ethnicity?
Conference Coverage
Flu shots may spark immune adverse events in PD-1 blockade for NSCLC
GENEVA – More than half of patients who had received a trivalent influenza vaccine in a small study had immune-related adverse events.
From the Journals
Skin testing and decision support can clarify penicillin allergy
Many patients who report penicillin allergy actually can safely take it; skin testing and computerized decision support can identify them.
FDA/CDC
FDA: Recall of select EpiPen products
Meridian Medical Technologies has issued a voluntary recall for 13 lots of EpiPen products, according to the U.S. Food and Drug Administration.
Conference Coverage
Oral agent found promising for subset of chronic rhinosinusitis patients
ATLANTA – Patients with chronic rhinosinusitis tolerated dexpramipexole well and showed robust and tissue eosinophil–lowering activity.